Psychological studies of longer range L-DOPA therapy in Parkinsonism.
D000367:Age Factors; D001143:Arousal / Q000187:drug effects*; D001538:Bender-Gestalt Test; D003071:Cognition / Q000187:drug effects*; D003863:Depression / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004522:Educational Status; D004644:Emotions / Q000187:drug effects*; D005260:Female; D005425:Flicker Fusion; D006801:Humans; D007361:Intelligence Tests; D008950:MMPI; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D009048:Motor Skills / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D010468:Perceptual Disorders / Q000139:chemically induced; D012649:Self Concept; D013997:Time Factors; D014796:Visual Perception / Q000187:drug effects
D004295:Dihydroxyphenylalanine